‘Club drug’ variant wins FDA approval

Published March 8, 2019 5:00am ET



Developed in the early 1960s, ketamine first gained popularity as a battlefield anesthetic for wounded soldiers.

By the mid-1980s, it had achieved a second life as a club drug, due to its trippy, psychedelic effects and the accompanying sense of euphoria achieved by snorting an illicit powder version.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.